by Truveta staff | Mar 18, 2024 | Research
Overall, the rate of hospitalizations associated with respiratory viruses has decreased throughout February 2024 (-20.0%) compared to January 2024. While COVID- and influenza-associated hospitalizations decreased (-26.5% and -22.7%), all other respiratory viruses...
by Truveta staff | Dec 15, 2023 | Research
As 2023 draws to a close and we reflect on a busy and exciting year for Truveta, something that stands out is the breadth and depth of research Truveta Research has been able to produce using Truveta Data and Truveta Studio. From studying new Alzheimer’s disease...
by Truveta Research | Aug 31, 2023 | Research, Research Insights
Compared to July, Truveta Data shows a 70.1% increase in the rate of COVID-19 positive tests and a 74.1% increase in the percentage of hospitalizations associated with COVID. Compared to 7 days prior, we see an 11.2% increase in the rate of COVID positive tests and an...
by Truveta staff | Aug 22, 2023 | Data
RSV season, which typically starts in fall and peaks in winter, could look very different this year. With newly approved vaccines for older adults and pregnant women and an immunization for infants poised to roll out, public health experts are optimistic about...
by Terry Myerson, CEO | Jun 20, 2023 | Technology
I can’t imagine our country without the FDA continuously assessing the safety and efficacy of medical products, or our government without the CDC monitoring and guiding public health choices. And yet, we all saw during the pandemic that there is a clear opportunity...
